Technology
Health
Biotechnology
Armata Pharmaceuticals
$3.459876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.67 (24.10%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell ARMP and other stocks, options, ETFs, and crypto commission-free!
About
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. Read More The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA.
Employees
31
Headquarters
Los Angeles, California
Founded
2019
Market Cap
6.51M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
51.13K
High Today
$3.45
Low Today
$3.03
Open Price
$3.04
Volume
28.71K
52 Week High
$19.18
52 Week Low
$2.15
Collections
Technology
Health
Biotechnology
US
North America
News
Seeking AlphaMay 28
ARMP, BIOC among top gainers
Armata Pharmaceuticals (NYSEMKT:ARMP) +28% on encouraging AP-PA01 data. Biocept (NASDAQ:BIOC) +24% on being awarded Chinese Patent No. ZL201080019566.9 entitled, devices and methods of cell capture and analysis. The9 (NASDAQ:NCTY) +17% on signing a joint venture agreement (the "JV agreement") with Shenzhen EN-plus Technologies. Eldorado Gold (NYSE:EGO) +14% on optimism over Greek snap election. Anaplan (NYSE:PLAN) +12% on Q1 earnings. Jumei International Holding (NYSE:JMEI) +12% on share repurchase. S...
Price Paid on Robinhood
563% Higher
Right Now
Average Price Paid
$0.52
52 Week Low
$2.15
52 Week High
$19.18
Earnings
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
—